Sai Life Sciences is a leading integrated Contract Research, Development, and Manufacturing Organization (CRDMO), partnering with over 300 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialization of New Chemical Entities (NCEs).
With over 25 years of experience, we consistently deliver value through scientific excellence, quality, and responsiveness, supporting a diverse range of NCE development programs. Our customers include 18 of the top 25 global pharmaceutical companies (based on 2023 revenue).
We have over 3,000 professionals across R&D and manufacturing facilities in India, the UK, and the USA, enabling seamless global collaboration. Our global footprint includes Discovery Biology Lab Watertown (Greater Boston), USA, a Process R&D Lab at Manchester, UK, complemented by large-scale R&D and manufacturing infrastructure in India.
Committed to scientific excellence, we help advance breakthrough therapies by providing end-to-end solutions that support our partners from early discovery through commercial manufacturing.
Our bespoke services span the entire drug discovery and development continuum, including:
• Target Validation to Lead Candidate
• Lead identified to First-In-Human (FTIH) Trials
• Early phase (FTIH) to Late Phase pivotal supplies
• Late phase - Validation & filing
• Life cycle management of commercialized products